Are you looking for the right contract development and manufacturing organization (CDMO) to develop and manufacture your high potency active pharmaceutical ingredients (HPAPIs)? Or have you been unsure about the CDMO you’re currently working with? In this free webinar, the featured speaker will explore the critical factors that should be considered when identifying and evaluating CDMOs for HPAPI for development and manufacturing. Other topics of discussion include the value of different types of containment technology, the significance of protocol during equipment changeovers and the advantages of certain cleaning strategies. Additionally, the speaker will review the important role of quality assurance in HPAPI manufacturing and delve into the questions you should ask a CDMO about their capabilities and corporate commitment to processing these complex APIs.View webinar
More from Curia
While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lin...